Viewing nowCombinationA-Twin Tablet 40/5 mg
Telmisartan 40mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Samchundaeng Pharmaceutical Co., Ltd.

MFDS item code 201607295 · Approved 2016.12.27 · Insurance code 651204870
Treatment of essential hypertension not controlled with monotherapy
This medication is used for patients with essential hypertension who have difficulty controlling blood pressure with amlodipine or telmisartan monotherapy alone. It helps to effectively lower blood pressure and reduce the risk of cardiovascular disease. Therefore, it is recommended for individuals needing blood pressure management and is actively utilized in the treatment of hypertension.
The recommended dose of this medication is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). Before administering this medication, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not adequately controlled with an individual component as described below, switching directly to this medication may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medication 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. - 80/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or this medication 40/10 mg. Patients taking telmisartan and amlodipine concomitantly may switch to this medication (a combination product with the same amounts of each active ingredient) for convenience (limited to this medication 40/5 mg and 80/10 mg). ○ Patients with renal impairment: No dosage adjustment is required for patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring caution when administered’). In older adults aged 75 years and above, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
The safety and efficacy of this medication have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.
This medication can cause serious harm to the fetus during pregnancy, especially in the second and third trimesters, so it should not be taken by pregnant women or women who may become pregnant. This medication is contraindicated in patients with certain conditions. For example, patients with severely impaired liver or kidney function, hypotensive patients, or those with serious heart problems should not take this medication. Especially for nursing women, it is advisable to avoid taking this medication, and patients who are genetically hypersensitive to any component of this medication should also refrain from using it. Some patients may commonly experience side effects such as dizziness and edema, and more serious side effects can occur infrequently, so if abnormal symptoms arise during use, it is important to consult a doctor immediately. It is essential to regularly check blood pressure, kidney function, and electrolyte levels during the use of this medication to ensure there are no abnormalities. This medication may interact with other drugs, so if you are currently taking other medications, be sure to inform your doctor or pharmacist. Caution is needed when driving or operating dangerous machinery, as drowsiness or dizziness may occur. In the case of overdose, symptoms such as hypotension and heart problems may arise, thus requiring immediate medical attention at a healthcare facility. This medication is not recommended for children as its safety and efficacy have not been adequately established in this population.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light, so it should be stored in a container that blocks light. It should also be kept at room temperature between 1 degree and 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication.
White or slightly off-white double convex oval tablet
30 tablets (10 tablets/Alu-Alu) X 3
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Samchundaeng Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
ILDONG Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.